237 related articles for article (PubMed ID: 29865280)
41. Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction.
Pittman N; Misseldine A; Geilen L; Halder S; Smith JK; Kurian J; Chipman P; Janssen M; Mckenna R; Baker TS; D'Abramo A; Cotmore S; Tattersall P; Agbandje-McKenna M
Viruses; 2017 Oct; 9(11):. PubMed ID: 29084163
[TBL] [Abstract][Full Text] [Related]
42. [Oncolytic parvoviruses. A new approaches for cancer therapy].
Loktev VB; Ivan'kina TIu; Netesov SV; Chumakov PM
Vestn Ross Akad Med Nauk; 2012; (2):42-7. PubMed ID: 22642177
[TBL] [Abstract][Full Text] [Related]
43. Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.
Le Boeuf F; Selman M; Son HH; Bergeron A; Chen A; Tsang J; Butterwick D; Arulanandam R; Forbes NE; Tzelepis F; Bell JC; Werier J; Abdelbary H; Diallo JS
Int J Cancer; 2017 Sep; 141(6):1257-1264. PubMed ID: 28568891
[TBL] [Abstract][Full Text] [Related]
44. An armed oncolytic herpes simplex virus expressing thrombospondin-1 has an enhanced in vivo antitumor effect against human gastric cancer.
Tsuji T; Nakamori M; Iwahashi M; Nakamura M; Ojima T; Iida T; Katsuda M; Hayata K; Ino Y; Todo T; Yamaue H
Int J Cancer; 2013 Jan; 132(2):485-94. PubMed ID: 22729516
[TBL] [Abstract][Full Text] [Related]
45. Anticancer effects of an oncolytic parvovirus combined with non-conventional therapeutics on pancreatic carcinoma cell lines.
Raykov Z; Georgieva PB; Angelova A; Galabov AS; Rommelaere J
Acta Virol; 2009; 53(1):57-60. PubMed ID: 19301953
[TBL] [Abstract][Full Text] [Related]
46. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
47. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
48. Tumor Selectivity of Oncolytic Parvoviruses: From in vitro and Animal Models to Cancer Patients.
Angelova AL; Geletneky K; Nüesch JP; Rommelaere J
Front Bioeng Biotechnol; 2015; 3():55. PubMed ID: 25954743
[TBL] [Abstract][Full Text] [Related]
49. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
[TBL] [Abstract][Full Text] [Related]
50. Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis.
Lavie M; Struyf S; Stroh-Dege A; Rommelaere J; Van Damme J; Dinsart C
Virology; 2013 Dec; 447(1-2):221-32. PubMed ID: 24210118
[TBL] [Abstract][Full Text] [Related]
51. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
52. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
[TBL] [Abstract][Full Text] [Related]
53. The antitumor effects of oncolytic adenovirus H101 against lung cancer.
Lei J; Li QH; Yang JL; Liu F; Wang L; Xu WM; Zhao WX
Int J Oncol; 2015 Aug; 47(2):555-62. PubMed ID: 26081001
[TBL] [Abstract][Full Text] [Related]
54. Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
Megison ML; Gillory LA; Stewart JE; Nabers HC; Mroczek-Musulman E; Waters AM; Coleman JM; Kelly V; Markert JM; Gillespie GY; Friedman GK; Beierle EA
PLoS One; 2014; 9(1):e86843. PubMed ID: 24497984
[TBL] [Abstract][Full Text] [Related]
55. Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans.
Bramante S; Koski A; Kipar A; Diaconu I; Liikanen I; Hemminki O; Vassilev L; Parviainen S; Cerullo V; Pesonen SK; Oksanen M; Heiskanen R; Rouvinen-Lagerström N; Merisalo-Soikkeli M; Hakonen T; Joensuu T; Kanerva A; Pesonen S; Hemminki A
Int J Cancer; 2014 Aug; 135(3):720-30. PubMed ID: 24374597
[TBL] [Abstract][Full Text] [Related]
56. Mutations in the Non-Structural Protein-Coding Sequence of Protoparvovirus H-1PV Enhance the Fitness of the Virus and Show Key Benefits Regarding the Transduction Efficiency of Derived Vectors.
Hashemi H; Condurat AL; Stroh-Dege A; Weiss N; Geiss C; Pilet J; Cornet Bartolomé C; Rommelaere J; Salomé N; Dinsart C
Viruses; 2018 Mar; 10(4):. PubMed ID: 29584637
[TBL] [Abstract][Full Text] [Related]
57. Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment.
Dempe S; Lavie M; Struyf S; Bhat R; Verbeke H; Paschek S; Berghmans N; Geibig R; Rommelaere J; Van Damme J; Dinsart C
Cancer Immunol Immunother; 2012 Nov; 61(11):2113-23. PubMed ID: 22576056
[TBL] [Abstract][Full Text] [Related]
58. Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.
Neulinger-Muñoz M; Schaack D; Grekova SP; Bauer AS; Giese T; Salg GA; Espinet E; Leuchs B; Heller A; Nüesch JPF; Schenk M; Volkmar M; Giese NA
Viruses; 2021 May; 13(6):. PubMed ID: 34071585
[TBL] [Abstract][Full Text] [Related]
59. Oncolytic parvoviruses: from basic virology to clinical applications.
Marchini A; Bonifati S; Scott EM; Angelova AL; Rommelaere J
Virol J; 2015 Jan; 12():6. PubMed ID: 25630937
[TBL] [Abstract][Full Text] [Related]
60. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
